4 recruiting. 4 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Recruiting 4 |
| Phase 2 | 1 | Recruiting 1 |
Follow Malignant Solid Neoplasm: new trials by email Literature Review of Malignant Solid Neoplasm trials Research Report on Malignant Solid Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Interstitial Photodynamic Therapy Following Palliative Radiotherapy in Treating Patients With Inoperable Malignant Central Airway Obstruction Biospecimen Collection, Computed Tomography, Endobronchial Ultrasound Bronchoscopy - Malignant Solid Neoplasm | Phase 1 / Phase 2 | Recruiting | Roswell Park Cancer Institute | 42 | 2024-10-01 | 2026-04-06 |
| Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax Atezolizumab, Cabozantinib S-malate, Nab-paclitaxel - Advanced Breast Carcinoma, Advanced Endometrial Carcinoma | Phase 1 | Recruiting | M.D. Anderson Cancer Center | 43 | 2022-04-29 | 2026-07-16 |
| Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer Best Practice, Biospecimen Collection, Endoscopic Procedure - Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8 | Phase 1 | Recruiting | M.D. Anderson Cancer Center | 800 | 2021-02-21 | 2026-07-15 |
| Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO Biospecimen Collection, Cabozantinib, Fluoropyrimidine - Autoimmune Disease, Crohn Disease | Phase 1 | Recruiting | National Cancer Institute (NCI) | 300 | 2019-07-16 | 2026-10-05 |
Arthritis, Psoriatic (1) · Arthritis, Rheumatoid (1) · Autoimmune Diseases (1) · Breast Neoplasms (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Renal Cell (1) · Colitis (1) · Colitis, Ulcerative (1) · Crohn Disease (1) · Dermatomyositis (1) · Endometrial Neoplasms (1) · Fallopian Tube Neoplasms (1) · Hematologic Neoplasms (1) · Inflammatory Bowel Diseases (1)
Digestive System Diseases (3) · Neoplasms (3) · Neoplasms by Site (3) · Colonic Diseases (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Gastroenteritis (2) · Gastrointestinal Diseases (2) · Intestinal Diseases (2) · Male Urogenital Diseases (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2) · Urogenital Diseases (2) · Adenocarcinoma (1) · Adnexal Diseases (1)
Specimen Handling (2) · cabozantinib (2) · 130-nm albumin-bound paclitaxel (1) · Albumin-Bound Paclitaxel (1) · CT-P13 (1) · CTLA-4 Antigen (1) · Disulfides (1) · Endoscopy (1) · Exercise Test (1) · Fecal Microbiota Transplantation (1) · Immunoglobulin G (1) · Infliximab (1) · Ipilimumab (1) · LDP-02 (1) · Nivolumab (1)
M.D. Anderson Cancer Center (2) · National Cancer Institute (NCI) (1) · Roswell Park Cancer Institute (1)
United States (4) · Canada (1)
Apostolia M Tsimberidou (1) · Hussein A Tawbi (1) · Nathaniel Ivanick (1) · Yinghong Wang (1)
R01CA283547 (1), UM1CA186688 (1)